TARA TRENHAILE: Open Payments
NPI 1821614991 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 24 payments from 11 companies in 2025. Trend: 2023 $339 · 2024 $326 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $213 |
| Amgen Inc. | 2 | $141 |
| Lilly USA, LLC | 5 | $93 |
| Tandem Diabetes Care, Inc. | 3 | $83 |
| Insulet Corporation | 1 | $66 |
| Ascendis Pharma Endocrinology Inc | 2 | $48 |
| Corcept Therapeutics | 2 | $33 |
| Dexcom, Inc. | 1 | $26 |
| Sequel Med Tech, LLC | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
Products named: Ozempic, EVENITY, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, Omnipod, Yorvipath, Korlym, Rybelsus.
Industry payments across FL — which companies pay providers there.
